Home New Trending Search
About Privacy Terms
#
#MedTwitter
Posts tagged #MedTwitter on Bluesky
Post image

Analysis of 7,582 recommendations from 23 U.S. medical societies (2019–2023):
• 67% of all recs had evidence matching their strength
• But 73% of strong recommendations rested on weaker evidence 😬
#MedTwitter #EBM @Anand_Habib @jsross119 @reshmagar rdcu.be/eYnAg

2 0 0 0

#SoMe4Surgery #MedTwitter #SurgEd #Surgery #MedicalTechniques #StepUp4CRC #ERAS #Crohn #proctology #TeachMeColoproctology #Some4COLoprocto @bjsacademy.bsky.social @martyn-evans.bsky.social @drjuliomayol.bsky.social @bjsopen.bsky.social @gio-marchegiani.bsky.social @malinasund.bsky.social

0 0 0 0
Video thumbnail

Things are in full swing at the 19th Annual NY GU Cancers Congress! Check back at onclive.com for all of our coverage of the meeting #oncology #medtwitter #kcsm #GUcancer

0 0 0 0
Preview
The hidden risks of AI-generated progress notes in psychotherapy Discover how AI-generated progress notes are changing mental health care. Learn why relying on AI in psychotherapy may improve efficiency but risks erasing the patient's story.

The hidden risks of #AI-generated progress notes in #psychotherapy

kevinmd.com/2026/03/the-...

#MedTwitter #AImedicine #AI #HealthAI #AIinHealthcare #MedTech

1 0 0 0
Post image

Let's look at delirium and dementia:

Episodes of delirium: more rapid progression of dementia.

Delirium survivors: x3-fold higher risk of future dementia.


➡️ We really need the support of dementia charities in helping improve delirium care.


#delirium #dementia #medtwitter

2 2 0 0
Post image

For #SleepAwarenessWeek, we’re highlighting Dr. Susheel Patil’s new paper in
@JCSMjournal
on refining the "bible" of sleep medicine diagnostic criteria.

Better data = More accurate care. 💤Article at link in bio.

#SleepMedicine #MedTwitter #HealthInnovation

0 0 0 0

🧠 Delirium = the only dedicated delirium journals.

👍100% open access.

👍Ultra-low fees ($20 submission, $280 publication).

👍All study types welcome & rapid 4-week peer review.


#delirium #medtwitter

0 1 0 0
Grand Rounds

Grand Rounds

Grand Rounds Speaker Bio

Grand Rounds Speaker Bio

Tomorrow: We welcome Pandurangan Vijayanand, M.D., Ph.D., to PCCSM&P Grand Rounds! #MEDTWITTER #MEDED #Asthma
@ucsdhealthsci.bsky.social @ucsdmedschool.bsky.social @lji.org

2 2 0 0
WVU Medicine bringing AI into the doctors office
WVU Medicine bringing AI into the doctors office YouTube video by WBOY 12 News

WVU #Medicine bringing #AI into the #doctors office

www.youtube.com/watch?v=zFNL...

#MedTwitter #AImedicine #AI #HealthAI #AIinHealthcare #MedTech

0 0 0 0
Preview
How a memory-augmented agent improves end-of-life decision-making A multi-artificial intelligence agent architecture triggers high-risk patient advanced care planning to improve clinical workflows and patient experiences, while integrating critical human steps for a...

How a memory-augmented agent improves end-of-life decision-making | #Healthcare IT News

www.healthcareitnews.com/news/how-mem...

#MedTwitter #AImedicine #AI #HealthAI #AIinHealthcare #MedTech

0 0 0 0
Preview
CaseHippo One platform for interactive learning, engagement and collaborative knowledge

Rapidly progressive GN. Nephrotic vs nephritic presentations. Emerging diagnostic tools.

Are your management strategies aligned with the latest evidence?

📚 bit.ly/4r5CHV8

#EvidenceBasedMedicine #Nephrology #RenalEducation #KidneyProfessionals #CME #MedTwitter #FOAMed

0 0 0 0
Preview
Dissecting the Importance of Timing in Gynecologic Cancer Clinical Trials | OncLive John Moroney, MD, and Katherine Kurnit, MD, MPH, emphasize the importance of timing in gynecologic cancer clinical trials.

📹 Katherine Kurnit, MD, and John Moroney, MD, of @uchicagocancer.bsky.social discuss the importance of timing in gynecologic cancer clinical trials. #oncology #medtwitter #gynecologiccancer
👉Watch here: www.onclive.com/view/dissect...

3 2 0 0
Preview
Dr Galsky on the Design of the KEYNOTE-B15 Trial in MIBC | OncLive Matthew D. Galsky, MD, unpacks the design of the phase 3 KEYNOTE-B15 in patients with MIBC.

📹 @mattgalsky.bsky.social of @mountsinainyc.bsky.social unpacks the design of the phase 3 KEYNOTE-B15 in patients with MIBC. #oncology #medtwitter #MIBC #bladdercancer
Watch here: www.onclive.com/view/dr-gals...

1 0 0 0

#Day22

Rheumatoid arthritis is diagnosed with your hands first, labs second.
careful physical exam can reveal:
• Symmetric MCP & PIP swelling
• Morning stiffness clues
• Tender joint counts
• Early deformities (ulnar deviation, boutonnière)

#Rheumatology #MedTwitter

0 0 0 0

#BioTerrorAgents #Anthrax #Botulism #Plague #SmallPox #Tularemia #FIFAWorldCup #CommunicableDisease #InfectiousDisease #MedTwitter #NurseTwitter #IDTwitter #InfectionPrevention #HealthCare #HealthcareWorkers #FrontLineWorkers #EssentialWorkers #StaySafe #EmorySCDU

0 0 0 0

#SoMe4Surgery #MedTwitter #SurgEd #Surgery #MedicalTechniques @bjsacademy.bsky.social @martyn-evans.bsky.social @drjuliomayol.bsky.social @bjsopen.bsky.social @gio-marchegiani.bsky.social @malinasund.bsky.social

0 0 0 0
Post image

Involved in #anesthesia research? IARS wants your input! Don't miss your chance to shape global resources! Last chance to take this quick survey before March 12: buff.ly/8iUe071 #Anesthesiology #PerioperativeMedicine #MedTwitter #ResearchSupport #IARS

0 0 0 0
Preview
The Chronic Constellation- the Double Trifecta of Co-morbid Conditions The Chronic Constellation- a look at the collection of co-morbid conditions that we see common in the hypermobile and autistic community.

The RCCX hypothesis *may* explain why #hEDS and the #HSD come with so many comorbidities:

ohtwist.com/the-chronic-...

#EDS #CFS #meded #EhlersDanlos #hypermobility #CAH #ME #Spoonie #POTS #MCAS #MyalgicE #MedTwitter #NEISvoid

8 0 3 0
Preview
The Ehlers-Danlos syndromes GP Toolkit A guide for GP's to approaching the management of people who have EDS in a primary care setting, as well as indications for onward referral

Share the #EDSToolkit for doctors spearheaded by Dr. Reinhold in 2018 for NHS GPs, but available to anyone willing to learn more about #EhlersDanlos & #hypermobility Spectrum Disorders!

gptoolkit.ehlers-danlos.org

#MedEd #FOAMed #MedTwitter #NEISvoid

3 1 0 0

this just makes me miss #medTwitter which was a sort of angry shitpost heaven type thing

4 0 0 0
Post image

#VExUS lets us see how that high pressure is affecting flow through our major organs. 🩸🌊

Is the kidney "congested" or just the IVC?

See the "how-to" and grading below, courtesy of
@nephropocus.bsky.social
:

🔗 nephropocus.com/2020/12/12/w...

#NephMadness #MedTwitter

5 2 1 0

#RespiratoryPathogens #Pathogens #FIFAWorldCup #CommunicableDisease #InfectiousDisease #MedTwitter #NurseTwitter #IDTwitter #InfectionPrevention #HealthCare #HealthcareWorkers #FrontLineWorkers #EssentialWorkers #StaySafe #CEU #EmorySCDU

0 0 0 0
Post image

That familiar feeling when a positive 4AT screening test vanishes into the EHR ether.

It's good that we are doing more tests - but it's only half the job.


𝟒𝐀𝐓 +𝐯𝐞 ➡️ "𝐝𝐞𝐥𝐢𝐫𝐢𝐮𝐦" 𝐢𝐧 𝐭𝐡𝐞 𝐧𝐨𝐭𝐞𝐬 + 𝐚𝐧 𝐚𝐜𝐭𝐢𝐨𝐧 𝐩𝐥𝐚𝐧.


#Delirium #MedTwitter

1 0 0 0
Minister standing at podium in front of backdrop reading

Official Welcome

The Hon Timothy Nichols, MP

Queensland Minister for Health and Ambulance Services

Minister standing at podium in front of backdrop reading Official Welcome The Hon Timothy Nichols, MP Queensland Minister for Health and Ambulance Services

Day 2 at #SPICA26 opens with the Minister for Health. Many strong feelings in the room, both positive and negative, but everyone (including Minister) was relatively restrained 😅.
#MedTwitter

1 0 0 0
NHS tops public trust rankings for AI use - Health Tech World New research from Appian (Nasdaq: APPN) shows the NHS is the most trusted organisation for responsible AI use, ranking higher than any other public or private sector organisation, including banks, ret...

🇬🇧 #NHS tops public trust rankings for #AI use - #Health #Tech World

www.htworld.co.uk/news/ai/nhs-...

#MedTwitter #AImedicine #AI #HealthAI #AIinHealthcare #MedTech

1 0 0 0
Preview
Dr Picozzi on the Significance of the PANOVA-3 Study for Future TTField Development in Pancreatic Cancer | OncLive Vincent Picozzi, MD, discusses how data from the phase 3 PANOVA-3 trial are foundational for the evaluation of Optune Pax with other immunotherapies.

📹Watch: Vincent Picozzi, MD, discusses how data from the phase 3 PANOVA-3 trial are foundational for the evaluation of Optune Pax with other immunotherapies in pancreatic cancer. #oncology #medtwitter #pcsm
👉Watch the full video here: www.onclive.com/view/dr-pico...

0 0 0 0

#SoMe4Surgery #MedTwitter #SurgEd #Surgery #MedicalTechniques @bjsacademy.bsky.social @martyn-evans.bsky.social @drjuliomayol.bsky.social @bjsopen.bsky.social @gio-marchegiani.bsky.social @malinasund.bsky.social

0 0 0 0
Dr Ali at podium in front of a slide reading

COMPLEX MEDICAL HISTORY HAVING MODERATE TO HIGH RISK SURGERY
. Significant Cardiac History. CCF with EF < 30%, severe valvular heart disease, severe IHD or medical therapy
. Respiratory failure. On home O2, FEV1 < 40% predicted
. Poor neurological function. Major CVA with significant deficits, debilitating neurological disease, significant cognitive impairment
. Renal failure. On dialysis or eGFR < 30
. Liver Failure. Child Pugh B or C
. Severely malnourished. Albumin < 25
. Morbidly obese. BMI > 50

FRAIL PATIENTS
Needing multidisciplinary input, e.g. geriatrics, ICU, allied health

POSSIBLE NON-BENEFICIAL SURGERY
0When we can help with making a decision not to proceed with surgery

Dr Ali at podium in front of a slide reading COMPLEX MEDICAL HISTORY HAVING MODERATE TO HIGH RISK SURGERY . Significant Cardiac History. CCF with EF < 30%, severe valvular heart disease, severe IHD or medical therapy . Respiratory failure. On home O2, FEV1 < 40% predicted . Poor neurological function. Major CVA with significant deficits, debilitating neurological disease, significant cognitive impairment . Renal failure. On dialysis or eGFR < 30 . Liver Failure. Child Pugh B or C . Severely malnourished. Albumin < 25 . Morbidly obese. BMI > 50 FRAIL PATIENTS Needing multidisciplinary input, e.g. geriatrics, ICU, allied health POSSIBLE NON-BENEFICIAL SURGERY 0When we can help with making a decision not to proceed with surgery

Dr Riedel at podium in front of a slide with a pyramid captioned 'Multimodal Prehabilitation within a stepped care framework' and additional slide text-

UNIVERSAL PREHABILITATION (Bottom level)

SPECIALIST
PREHABILITATION (middle level)
Pre-frail
Malnourished
Deconditioned (unfit)

TARGETED PREHABILITATION (top level)
Frail
Sarcopenia

Dr Riedel at podium in front of a slide with a pyramid captioned 'Multimodal Prehabilitation within a stepped care framework' and additional slide text- UNIVERSAL PREHABILITATION (Bottom level) SPECIALIST PREHABILITATION (middle level) Pre-frail Malnourished Deconditioned (unfit) TARGETED PREHABILITATION (top level) Frail Sarcopenia

More gold #SPICA26- Dr Farheen Ali emphasizes referral to periop medicine services has to be *easy*. Simple tickboxes at Westmead ✅️. And Dr Bernhard Riedel talks about the prehabilitation pyramid and why the bottom level should be UNIVERSAL provision.
#MedTwitter

5 0 0 0
Preview
Bilal Awad: Case Report on Osteosarcoma Recurrence Complicated by Empyema - OncoDaily Bilal Awad: Case Report on Osteosarcoma Recurrence Complicated by Empyema / Bilal Awad, cancer, case report, OncoDaily, Oncology, osteosarcoma

Case Report on Osteosarcoma Recurrence Complicated by Empyema - Bilal Awad

@bilalawad83.bsky.social

oncodaily.com/voices/bilal...

#OncoDaily #Oncology #Cancer #Health #Osteosarcoma #Medicine #MedX #MedTwitter

0 0 0 0
Preview
Dr Chandra on the Label Update for Cosibelimab in Cutaneous Squamous Cell Carcinoma | OncLive Sunandana Chandra, MD, discusses the current systemic treatment landscape for patients with unresectable, locally advanced, or metastatic cutaneous squamous cell carcinoma.

🎥 Sunandana Chandra, MD, of @luriecancer.bsky.social and breaks down the updated FDA label for cosibelimab (Unloxcyt) in advanced cutaneous squamous cell carcinoma 👩‍⚕️🧴 #CSCC #oncology #Immunotherapy #MedTwitter
Watch here 👉 www.onclive.com/view/dr-chan...

0 0 0 0